Eli Lilly & Co. (LLY)
927.03
+23.04
(+2.55%)
USD |
NYSE |
Apr 17, 16:00
926.02
-1.01
(-0.11%)
After-Hours: 20:00
Eli Lilly SG&A Expense (Quarterly) : 3.132B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Viking Therapeutics, Inc. | 11.28M |
| Apellis Pharmaceuticals, Inc. | 147.10M |
| Arcellx, Inc. | 31.24M |
| Moderna, Inc. | 308.00M |